Dexcom (DXCM) Total Current Liabilities (2010 - 2026)
Dexcom (DXCM) posted quarterly Total Current Liabilities of $2.4 billion for Q2 2026, down 28.74% year-over-year from $3.3 billion in Q2 2025, and up 6.02% quarter-over-quarter from $2.2 billion in Q1 2026.
Dexcom (DXCM) Total Current Liabilities (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Total Current Liabilities for 17 consecutive years, with $2.4 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities fell 28.74% year-over-year to $2.4 billion; the TTM figure through Jun 2026 stood at $2.4 billion (down 28.74% YoY), while the FY2025 annual figure was $2.1 billion, down 26.93% from the prior year.
- Total Current Liabilities advanced to $2.4 billion in Q2 2026 per DXCM's latest filing, from $2.2 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $3.3 billion in Q3 2025 and bottomed at $711.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $2.0 billion across 5 years, with a median of $1.9 billion in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities soared 162.16% — and 2026, when it decreased 28.74%.
- Dexcom's Total Current Liabilities stood at $1.8 billion in 2022, then fell by 15.4% to $1.6 billion in 2023, then surged by 88.43% to $2.9 billion in 2024, then dropped by 26.93% to $2.1 billion in 2025, then gained by 10.04% to $2.4 billion in 2026.
- Business Quant data shows DXCM's Total Current Liabilities at $2.4 billion in Q2 2026, $2.2 billion in Q1 2026, and $2.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 19.25 Bn | 18.84 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.36 Bn |
| Mar 31, 2026 | 2.22 Bn |
| Dec 31, 2025 | 2.14 Bn |
| Sep 30, 2025 | 3.34 Bn |
| Jun 30, 2025 | 3.31 Bn |
| Mar 31, 2025 | 3.04 Bn |
| Dec 31, 2024 | 2.93 Bn |
| Sep 30, 2024 | 1.73 Bn |
| Jun 30, 2024 | 1.72 Bn |
| Mar 31, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.56 Bn |
| Sep 30, 2023 | 1.68 Bn |
| Jun 30, 2023 | 2.07 Bn |
| Mar 31, 2023 | 1.87 Bn |
| Dec 31, 2022 | 1.84 Bn |
| Sep 30, 2022 | 900.50 Mn |
| Jun 30, 2022 | 807.00 Mn |
| Mar 31, 2022 | 711.40 Mn |
| Dec 31, 2021 | 720.80 Mn |
| Sep 30, 2021 | 734.90 Mn |